Release Date: 28/02/11 17:01 Summary: Notice of General Meeting of Shareholders Price Sensitive: No Download Document 632.92KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%